Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000033

CEO bought 15,000 shares at an average $0.17 ($2,475)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2015-07-16 Purchase : show line 1 in the form +5,000 $0.17 $850 4,526,580 D
2015-07-17 Purchase : show line 2 in the form +5,000 $0.16 $800 4,531,580 D
2015-07-17 Purchase : show line 3 in the form +5,000 $0.17 $825 4,536,580 D
Open-market purchases · 15,000 sh · avg $0.17 · $2,475
Loading xslF345X03/primary_doc.xml…